Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.
Research published in the April print edition of the journal Life Science Alliance, shows that antidepressant drugs called FIASMAs, including desipramine, amitriptyline, and nortriptyline, halt the growth or kill four different intracellular bacterial pathogens in tissue cell culture and animal models.
“Antibiotic options for diseases caused by intracellular bacteria are limited because many of these drugs cannot penetrate our cell membranes. In essence, the bacteria are protected,” said Jason Carlyon, Ph.D., leader of the study and professor in the VCU Department of Microbiology and Immunology.
Tetracycline antibiotics are most commonly prescribed to treat intracellular bacterial infections because they can cross cell membranes to reach the microbes. However, tetracyclines can cause allergic reactions in some patients and physicians advise against their use by pregnant women and children due to undesirable side effects. Additionally, antibiotic resistance in some intracellular bacteria has been reported.
“It would be highly beneficial to have a class of drugs to treat such diseases in patients for whom tetracyclines are contraindicated,” Carlyon said. “These drugs could provide an alternative to antibiotics or even be used in conjunction with them as an augmentation approach to treat infections that typically require prolonged courses of antibiotic therapy, such as those caused by Chlamydia pneumoniae and Coxiella burnetti.”
The team of researchers from VCU, Indiana University Medical Center, University of Nebraska Medical Center, University of Arkansas for Medical Sciences, and the University of South Florida, including Carlyon and lead author Chelsea Cockburn, an M.D.-Ph.D. candidate, are the first to investigate the mechanisms by which FIASMAs target multiple intracellular bacteria in detail.
The scientists tested FIASMA susceptibility for four bacterial species that cause human granulocytic anaplasmosis, a tick-borne disease that attacks white blood cells called neutrophils and can be fatal to immune compromised individuals; Q fever, a debilitating pneumonic disease; and two chlamydia infections.
FIASMAs ultimately disrupt how cholesterol, a key nutrient utilized by many intracellular pathogens, traffics inside cells to alter bacterial access to the lipid. The researchers first proved FIASMA treatment efficacy by halting anaplasmosis in both tissue culture and mice. Next, they extended their observations to demonstrate that FIASMA treatment killed the Q fever agent,Coxiella burnetii, and partially inhibited chlamydial infections in cell culture.
“Since FIASMAs influence cholesterol trafficking in the cell and cholesterol plays a role in so many facets of our biology, they have been used to treat a wide variety of conditions and diseases,” Carlyon said.
He added that the effect of FIASMAs on intracellular cholesterol ultimately bypasses the need to directly target the bacteria.
“What is so exciting about this study is that the class of drugs we evaluated targets an enzyme in our cells regulating cholesterol, not the bacteria,” Carlyon said. “I do not envision the pathogens being able to develop resistance to this treatment because it is targeting a host pathway that they very much need to grow and survive inside of the body.”
The Latest on: Alternative to antibiotics
via Google News
The Latest on: Alternative to antibiotics
- The different paths turkeys take to the table on the East Coaston October 7, 2020 at 1:28 pm
South Maitland, N.S. free-range turkey farmer Marvin Weber says people don’t mind paying extra for his turkeys on Thanksgiving, since it’s a treat. - SaltWire Network Turkey time is fast approaching.
- Antibiotics or Appendectomy? Both Good Optionson October 7, 2020 at 4:14 am
A large, randomized trial finds antibiotics are noninferior to surgery after 30 days. However, experts urge caution in rushing to the medication option for everyone.
- Dubious Alternative Lyme Treatments Are Killing Patientson October 7, 2020 at 2:00 am
Cartwright had been diagnosed with Lyme disease in 2003, and she’d suffered persistent symptoms ever since: coughing, runny nose, joint aches, poor sleep, low energy. She’d been forced to retire from ...
- Fly larvae extract will replace antibiotics in fighting plant pathogenson October 5, 2020 at 9:40 am
Biotechnologists from MIPT have developed a method for extracting the active constituents from the fat of black soldier fly larvae. These compounds possess unique antimicrobial properties and can ...
- The journey to developing tick-borne disease vaccineon October 2, 2020 at 5:00 pm
Traditional methods for the control of tick infestations have been based on use of acaricides, repellents, antibiotics, cattle breeding and ... Anti-tick vaccines constitute an effective and ...
- TGen and HonorHealth study suggests alternative method of diagnosing lung infectionon September 30, 2020 at 9:00 pm
As ventilator use in hospitals skyrockets during the COVID-19 pandemic, results of a study by the Translational Genomics Research Institute, City of Hope, HonorHealth Research and Innovation Institute ...
- Locus Biosciences signs contract with BARDA to advance $144 million precision medicine program to develop LBP-EC01, a crPhage™ producton September 30, 2020 at 6:00 am
Locus Biosciences announced today that it has signed a contract with the Biomedical Advanced Research and Development Authority (BARDA) to co-fund development of LBP-EC01, a CRISPR Cas3-enhanced ...
- A Tapas Restaurant Plans to Open Next to BurgerFi in Hendersonon September 28, 2020 at 11:00 am
Located close to the intersection of St. Rose Parkway and Coronado Center, BurgerFi specializes in antibiotic-, steroid-, and additive-free Black Angus beef burgers on buns toasted with the company ...
- Infusion pump recall has hospitals scrambling whether to replace, repair themon September 25, 2020 at 1:17 pm
A voluntary safety recall of widely used Alaris infusion pumps has several health systems in Michigan and others nationally scrambling to replace or repair them or educate provide ...
- Boron nitride nanofilms will replace antibiotics for protection against bacterial and fungal infectionson September 14, 2020 at 8:05 am
They can become a safe alternative to the usual antibiotics in implantology since they do not have typical negative side effects. The results of the work are published in ACS Applied Materials ...
via Bing News